Expert Pitch

Market Turbulence from Covid-19, OPEC: Maryland Smith Finance Experts Available

University of Maryland, Robert H. Smith School of Business

Looking for an expert who can lend some context to the current gyrations in the financial markets? The following experts from the University of Maryland’s Robert H. Smith School of Business are available to speak about financial sector disruption, in the wake of the developments about Covid-19 and OPEC.

Clifford Rossi, professor of the practice. With 25-plus years of experience as both a senior executive at top financial institutions and a federal-banking regulator, Rossi says individual investors can manage their risk like a bank, by applying value-at-risk, or VaR:

“Managing your own investment risk like a bank can provide a way to quantify your appetite for risk under a wide range of outcomes in a consistent and easily understood manner…The largest and most complex commercial banks apply value-at-risk, or VaR as it is known, as a technique to establish the outer bounds of risk for their institutions…Translating that to individual investment portfolios requires having a distribution of losses in your portfolio based on a simulation of market and macroeconomic factors over time.” 

David Kass, clinical professor of finance. Kass is an expert in corporate finance. He previously served as an economist in senior positions with the Federal Trade Commission, General Accounting Office, Department of Defense, and the Bureau of Economic Analysis. 

He recently told InvestorPlace: "The worldwide fear of the coronavirus is likely to result in the outperformance of health stocks in the near future … [but] biotech stocks trying to develop a vaccine for this virus … have already had large stocks moves to the upside. Instead of those highly visible potential beneficiaries of the spreading of this disease, I suggest looking elsewhere within the healthcare sector."

Kass, separately to the Baltimore Sun: “Most stock investors, I recommend, be long term. Short-term traders and speculators I can see being concerned. I believe the coronavirus probably will be resolved for the most part in a year, after more medical interventions are developed and available. The economy will start recovering and so would the stock market.” 

“Historically, the S&P 500, dividends included, have grown at a compounded rate of 10 percent since 1965. And, year-to-year, the SP 500, with dividends, has gone up in 80 percent of the years since 1942.”

Albert (Pete) Kyle, Charles E. Smith Chair Professor of Finance. Kyle can comment on Covid-19 effects as they relate to informed speculative trading, market manipulation, price volatility, the information content of market prices, market liquidity and contagion. Kyle served as a staff member of the Presidential Task Force on Market Mechanisms (Brady Commission, 1987), and has served as a member of the Financial Industry Regulatory Authority (FINRA) Economic Advisory Committee and the U.S. Commodity Futures Trading Commission's Technology Advisory Committee.

Elinda Kiss, associate clinical professor of finance. Kiss can discuss this topic in terms of her expertise in financial crises and personal finance. Her expanded areas of expertise include banking, banking regulation, the Federal Reserve, interest rates and student debt. 




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
3.37374